Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()

BACKGROUND: Bradykinin angioedemas are a potentially serious side effect of angiotensin-converting enzyme inhibitors (ACEI) and more controversially of angiotensin II receptor blockers (ARB). Their challenging diagnosis is based on the absence of any recurrence after more than 6 months of drug disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Douillard, Marie, Deheb, Zineb, Bozon, Agathe, Raison-Peyron, Nadia, Dereure, Olivier, Moulis, Lionel, Soria, Angèle, Du-Thanh, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458346/
https://www.ncbi.nlm.nih.gov/pubmed/37638360
http://dx.doi.org/10.1016/j.waojou.2023.100809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458346/
https://www.ncbi.nlm.nih.gov/pubmed/37638360
http://dx.doi.org/10.1016/j.waojou.2023.100809

Ejemplares similares